Estudo clínico-laboratorial do uso do fenobarbital como anticonvulsivante na Neuropediatria do HUAC: perfil epidemiológico dos usuários.

Abstract

Anticonvulsive drugs are common in medical practice, especially in the pediatric age group. It is a group of medication that stands out not only for the wide variety but also for the large number of adverse effects that may arrive with its use. In epilepsy the indication of such a prescription is well established, however, confirming this diagnosis is still a challenge. We present a research that seeks to know the clinical and epidemiological characteristics of drug users in order to subsidize pharmacotherapeutic adjustments and, in the future, the implementation of a therapeutic monitoring program by laboratory dosage with clinical correlations of the prescribed drugs. Focusing on the use of phenobarbital and its possible implications, mainly because in our country it is the drug most used by several factors, especially with regard to costs and access in the Unique Health System. Draw a profile of the users of these medications is remarkable, because besides stamping our closest reality, it offers us questions and tools so that we can deliver a better quality assistance at anticonvulsant pharmacotherapy.